Literature DB >> 1166792

Asymptomatic bacteriuria in school girls. V. The clinical course and response to treatment.

U Lindberg.   

Abstract

The short-term prognosis of 116 school girls with asymptomatic bacteriuria (ABU) treated or left untreated is reported. In untreated girls a spontaneous remission was obtained in 11% within one year. A short course of nitrofurantoin eliminated the bacteriuria in 93% of the girls in the treatment group. The recurrence rate was 30% in one year in the patients that became abacteriuric spontaneously, after a bladder washout test or after treatment with penicillin or nitrofurantoin. The first recurrence occurred withn 3 months in 79% (19/24). Nineteen of the 24 patients with recurrences (79%) had a third infection within 9 months. In patients with parenchymal reduction or reflux the renal concentrating capacity increased significantly after treatment of the bacteriuria. All the girls left untreated had normal renal concentrating capacity on detection and this remained unchanged during the year of follow-up. One of 28 untreated girls attracted a symptomatic pyelonephritis caused by a strain different from that at detection of ABU. Of 81 girls cured from the bacteriuria 24 recurred, 5 with a symptomatic pyelonephritis and 3 with cystitis. It is concluded that strains isolated from girls with ABU do not commonly cause symptomatic pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166792     DOI: 10.1111/j.1651-2227.1975.tb03910.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  6 in total

1.  Screening for bacteriuria in infants.

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

2.  Host-pathogen interactions mediating pain of urinary tract infection.

Authors:  Charles N Rudick; Benjamin K Billips; Vladimir I Pavlov; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

3.  Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.

Authors:  Charles N Rudick; Aisha K Taylor; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

4.  The co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions.

Authors:  Charalampos Harris Mavromatis; Nilesh J Bokil; Makrina Totsika; Asha Kakkanat; Kolja Schaale; Carlo V Cannistraci; Taewoo Ryu; Scott A Beatson; Glen C Ulett; Mark A Schembri; Matthew J Sweet; Timothy Ravasi
Journal:  Cell Microbiol       Date:  2015-01-24       Impact factor: 3.715

Review 5.  Deliberate Establishment of Asymptomatic Bacteriuria-A Novel Strategy to Prevent Recurrent UTI.

Authors:  Björn Wullt; Catharina Svanborg
Journal:  Pathogens       Date:  2016-07-29

Review 6.  Molecular determinants of disease severity in urinary tract infection.

Authors:  Ines Ambite; Daniel Butler; Murphy Lam Yim Wan; Therese Rosenblad; Thi Hien Tran; Sing Ming Chao; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2021-06-15       Impact factor: 14.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.